Early Phase Expertise
AGC Biologics' Berkeley California Facility is exclusively dedicated to early-phase development and manufacturing.
Located within one of the largest biotech hubs in the world, the Berkeley facility delivers targeted manufacturing services and capabilities specifically catered to our customers' critical early-phase needs.
CMC Biologics' Gustavo Mahler, interviewed during BioPharm International, 2016.
Dr. Mahler discusses the Biopharmacuetical industry and CMC Biologics technical capabilities, including Multi-Column Chromatography (MCC).
CMC Biologics' own Bob Broeze, interviewed during the June, 2016 BIO International. The discussion covers topics including how to evaluate and choose a CDMO, and the importance of expertise in guiding a commercial product through both the U.S. and European regulatory agencies.
